Edited by: Bodo Niggemann
Importance of serum basal tryptase levels in children with insect venom allergy
Article first published online: 18 JAN 2013
© 2013 John Wiley & Sons A/S. Published by Blackwell Publishing Ltd
Volume 68, Issue 3, pages 386–391, March 2013
How to Cite
Importance of serum basal tryptase levels in children with insect venom allergy. Allergy 2013; 68: 386–391., , , , , , , .
- Issue published online: 8 FEB 2013
- Article first published online: 18 JAN 2013
- Manuscript Accepted: 25 NOV 2012
- insect venom allergy;
- large local reaction;
- risk factors;
- serum basal tryptase;
- systemic reaction
The importance of serum basal tryptase (sBT) levels on patients with venom allergy is highlighted in recent adulthood studies. The aim of this study was to evaluate the sBT levels of venom-allergic children with varying severity of clinical reactions. We also aimed to document the association between sBT levels and severe systemic reactions (SR).
Serum basal tryptase levels were estimated by UniCAP (Pharmacia & Upjohn, Uppsala, Sweden). Children who suffered from large local reaction (LLR) or SR after insect stings were included along with healthy control subjects without a history of any local or SR after insect stings.
A total of 128 children (55 with SR, 18 with LLR, and 55 age and sex-matched control subjects) with a median age of 8.9 years (range 3.2–17.4) were enrolled. Severe SR was encountered in 24 (44%) patients with SRs. The median level of sBT in children with SRs (median, interquartile range) [4.2 μg/l (3.6–4.9)] was significantly higher than in children with LLRs [3.1 μg/l (2.5–4.0)] and healthy control subjects [2.9 μg/l (2.3–3.4)] (P < 0.001). Logistic regression analysis revealed sBT ≥ 4.8 μg/l as a significant risk factor for severe SR (5.7 [1.5–21.4]; P = 0.01) in children with venom allergy.
Our results indicate that sBT levels are associated with a higher risk of severe SR in children with insect venom hypersensitivity. Determination of sBT levels may help clinicians to identify patients under risk of severe SRs and optimal and timely use of therapeutic interventions in children with venom allergy.